Hanseatic Management Services Inc. Purchases New Position in Liquidia Corporation $LQDA

Hanseatic Management Services Inc. purchased a new stake in Liquidia Corporation (NASDAQ:LQDA) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 20,468 shares of the company’s stock, valued at approximately $772,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. purchased a new stake in shares of Liquidia during the 4th quarter worth approximately $25,000. NewEdge Advisors LLC purchased a new position in shares of Liquidia in the 2nd quarter valued at $25,000. FNY Investment Advisers LLC acquired a new stake in Liquidia during the 3rd quarter worth $34,000. Covestor Ltd raised its stake in Liquidia by 41.9% during the 4th quarter. Covestor Ltd now owns 1,216 shares of the company’s stock worth $42,000 after acquiring an additional 359 shares in the last quarter. Finally, Tower Research Capital LLC TRC raised its stake in Liquidia by 281.2% during the 2nd quarter. Tower Research Capital LLC TRC now owns 6,679 shares of the company’s stock worth $83,000 after acquiring an additional 4,927 shares in the last quarter. Institutional investors and hedge funds own 64.54% of the company’s stock.

Analysts Set New Price Targets

Several research firms have issued reports on LQDA. BTIG Research upped their price objective on shares of Liquidia from $59.00 to $109.00 and gave the company a “buy” rating in a research note on Monday, June 22nd. HC Wainwright lifted their target price on Liquidia from $67.00 to $75.00 and gave the stock a “buy” rating in a research report on Friday, June 5th. Weiss Ratings reissued a “sell (d-)” rating on shares of Liquidia in a report on Tuesday, April 21st. Jefferies Financial Group reissued a “buy” rating and issued a $60.00 target price on shares of Liquidia in a research report on Monday, May 11th. Finally, Wells Fargo & Company raised their price target on Liquidia from $51.00 to $62.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 12th. Three investment analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Liquidia has an average rating of “Moderate Buy” and a consensus target price of $68.88.

Liquidia Trading Up 6.2%

Shares of Liquidia stock opened at $79.94 on Friday. The company has a debt-to-equity ratio of 1.18, a quick ratio of 2.03 and a current ratio of 2.22. The company has a market capitalization of $7.11 billion, a P/E ratio of 571.04 and a beta of 0.55. Liquidia Corporation has a 1 year low of $14.25 and a 1 year high of $82.96. The company’s fifty day moving average is $68.49 and its two-hundred day moving average is $48.33.

Liquidia (NASDAQ:LQDA) last announced its earnings results on Monday, May 11th. The company reported $0.52 EPS for the quarter, beating analysts’ consensus estimates of $0.41 by $0.11. Liquidia had a net margin of 7.74% and a return on equity of 46.82%. The business had revenue of $132.87 million during the quarter, compared to analysts’ expectations of $119.44 million. Liquidia’s revenue was up 4187.1% compared to the same quarter last year. Analysts forecast that Liquidia Corporation will post 3.02 earnings per share for the current year.

Insider Activity

In other Liquidia news, CEO Roger Jeffs sold 35,249 shares of the stock in a transaction that occurred on Monday, July 13th. The stock was sold at an average price of $71.51, for a total transaction of $2,520,655.99. Following the completion of the sale, the chief executive officer directly owned 1,130,426 shares of the company’s stock, valued at approximately $80,836,763.26. This trade represents a 3.02% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Michael Kaseta sold 20,430 shares of Liquidia stock in a transaction that occurred on Monday, July 13th. The shares were sold at an average price of $71.51, for a total value of $1,460,949.30. Following the completion of the transaction, the chief financial officer owned 345,805 shares in the company, valued at $24,728,515.55. This trade represents a 5.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 2,022,134 shares of company stock worth $129,579,224 over the last quarter. 25.60% of the stock is owned by insiders.

Liquidia Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).